Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms — Thazin Nwe Aung (2022) | RDL Network
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms
Article 2022 en
Authors
TA
Thazin Nwe Aung
SS
Saba Shafi
JW
James S. Wilmott
Abstract
1 min read
This work was also supported by a sponsored research agreements from Navigate Biopharma and NextCure and by grants from the NIH including the Yale SPORE in in Skin Cancer, P50 CA121974, the Yale SPORE in Lung Cancer, P50 CA196530, NYU SPORE in Skin Cancer P50CA225450 and the Yale Cancer Center Support Grant, P30CA016359.
Andrei Gafita, Jérémie Calais, Tristan Grogan, Anna Zeldin, Boris Hadaschik, Hui Wang, Manuel Weber, Shahneen Sandhu, Clemens Kratochwil, Rouzbeh Esfandiari, Robert Tauber, Hendrik Rathke, Wesley R. Armstrong, Andrew Robertson, Pan Thin, Calogero D’Alessandria, Matthew B. Rettig, Ebrahim S. Delpassand, Uwe Haberkorn, David Elashoff, Ken Herrmann, Johannes Czernin, Prof Michael S. Hofman, Wolfgang P. Fendler, Matthias Eiber
Matthew R. Smith, Shahneen Sandhu, Daniel J. George, Kim Nguyen, Fred Saad, Antoine Thiery-Vuillemin, O. Ståhl, David Olmos, Daniel C. Danila, Rustem Gafanov, Elena Castro, Helen Moon, Anthony M. Joshua, Gary Mason, Byron M. Espina, Yan Liu, Angela Lopez‐Gitlitz, Peter Francis, Katherine B. Bevans, Karim Fizazi
J.S. Deutsch, Tricia R. Cottrell, Krista Chen, Carlos E. de Andrea, Pierre Fiset, Christine Orr, Jaime Rodriguez‐Canales, Roberto Salgado, Christian Schürch, Richard A Scolyer, Raja R. Seethala, Lynette M. Sholl, Sabina Signoretti, Michael T. Tetzlaff, Annikka Weissferdt, Xiaowei Xu, James Ziai, Hao Wang, Alexander S. Baras, Ashley Cimino‐Mathews,
Discussion(0)
No comments yet. Be the first to comment.